Pharmacies buy drugs from wholesalers, sell them to people who bring prescriptions and are reimbursed by the government for drugs on the PBS. They are also paid for the professional advice they provide when dispensing these drugs. The first EU agreement on pharmacies included a compensation package for pharmacists as well as a package of structural reforms aimed at promoting better distribution of pharmacies across Australia (through provisions restricting the opening of new pharmacies) and encouraging the closure or merger of pharmacies located in supercharged areas. The scope of subsequent agreements has been expanded to include funding for pharmacy programs (for example. B programs to assist patients in the management of their medications) and other issues. Any subsequent agreement has helped to maintain the principle of equitable distribution of pharmacies throughout the country through professional controls on the location rule, which stipulates that a pharmacy should not be open within 1.5 kilometres of an existing pharmacy. It is also not uncommon for parliamentary committees to examine aspects of EU pharmacy agreements. For example, in 2015, the Joint Committee on Public Finance and Audit reviewed the aforementioned ANAO report on the fifth EU Agreement on Pharmacies. Since 2005, the Australian government has funded a community service bond (ESC) funding pool.
The CSO Funding Pool ensures that all Australians have continuous access to all PBS drugs through community pharmacies. It provides financial support to pharmaceutical wholesalers and provides the entire supply of PBS drugs, regardless of where the pharmacy is being implemented and the relative delivery costs. With the municipality`s current pharmacy contract expiring on June 30, 2020, a new agreement is being negotiated. The Australian government pays licensed pharmacists for the provision of Pharmaceutical Benefit Scheme (PBS) drugs to patients. For Community pharmacists, the amount of remuneration is agreed between the government and the Pharmacy Guild of Australia (the Guild representing the majority of pharmacy owners) and set by pharmacy contracts for five consecutive years. ”I think it`s a good result for pharmacy owners that the Guild has achieved given the additional $1.2 billion,” he said. the proposal to simultaneously authorize the supply of two months of deliveries of certain PBS-based medicines for chronic diseases. This would reduce costs for patients and the government, but would reduce pharmacists` revenues from distribution and related costs. The guild rejects the proposal and complains about the impact on pharmacy facilities and the risk that patients will not take their medications properly. The current state of the proposal in the negotiations is unclear, with the Ministry of Health noting at the end of 2019 that ”the government will carefully consider the proposal and does not propose, at this stage, to change the quantities of PBS-based drugs.”